🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the long-term safety of anifroluma...
Status
Completed
Location
Research Site
Start Date
2013-03-28
Trial ID
NCT01753193
Treatments Being Tested
The purpose of this study is to assess safety, tolerability, pharmacokineti...
Status
Completed
Location
Research Site
Start Date
2012-04-20
Trial ID
NCT01559090
The purpose of this study is to evaluate the efficacy and safety of MEDI-54...
Status
Completed
Location
Research Site
Start Date
2012-01
Trial ID
NCT01438489
Treatments Being Tested
To provide early access (ie, before marketing authorisation) to anifrolumab...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04750057
Treatments Being Tested
A Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), Effic...
Status
Recruiting
Location
Research Site
Start Date
2024-03-14
Trial ID
NCT05835310
Treatments Being Tested
The purpose of this study is evaluating the efficacy and safety of SC antif...
Status
Active Not Recruiting
Location
Research Site
Start Date
2021-06-08
Trial ID
NCT04877691
The purpose of this study is to evaluate the efficacy and safety of IV anti...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-02-15
Trial ID
NCT05138133
Treatments Being Tested
This study to examines the impact of anifrolumab on disease activity, immun...
Status
Unknown
Location
Yale University Medical Center
Start Date
2021-01-20
Trial ID
NCT04726553
Treatments Being Tested
To evaluate the safety and tolerability of a multiple-dosed drug (MEDI-546)...
Status
Completed
Location
Research Site
Start Date
2009-09
Trial ID
NCT00930683
The purpose of this study is to characterize the pharmacokinetics (PK), pha...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-28
Trial ID
NCT07630714
Treatments Being Tested